Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or 317-615-4559
LillyTrials@Lilly.com


Physicians interested in becoming principal investigators please contact clinical_inquiry_hub@lilly.com


Study Location:

Find another location


Questions to ask
Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)
Back

A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)

Recruiting

Open to: ALL

Age: 18.0 - N/A

Ashton-under-Lyne Hyde SK14 Manchester Manchester Manchester Manchester Oldham Oldham Rochdale Salford Swinton Swinton

Medical Conditions

Obesity

This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.


The purpose of this study is to evaluate tirzepatide within a real-world setting to assess body weight loss and incidence of type 2 diabetes in adults without diabetes who have obesity and at least one weight-related comorbid condition. Participation in the study will last about 260 weeks.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

Nov 2025 Jul 2029

INTERVENTIONAL

Intervention Type : DRUG
Intervention Description : Administered SC

Intervention Arm Group : Tirzepatide + Standard of Care;

Intervention Type : OTHER
Intervention Description : Standard of care

Intervention Arm Group : Standard of Care;



You can take part if:



You may not be able to take part if:


This is in the inclusion criteria above


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • P89008 Ashton Medical Group
    Ashton-under-Lyne
    OL6 6EW
  • P89002 The Brooke Surgery
    Hyde SK14
    SK14 1AT
  • P84035 Bodey Medical Centre
    Manchester
    M14 6WP
  • P84630 The Arch Medical Practice
    Manchester
    M15 5TJ
  • P86004 Peterloo Medical Centre
    Manchester
    M24 4DZ
  • P87019 Silverdale Medical Practice
    Manchester
    M27 8 HP
  • P85010 Woodlands Medical Practice
    Oldham
    OL9 0LH
  • P85011 CH Medical Practice
    Oldham
    OL9 8NH
  • P86022 Stonefield Street Surgery
    Rochdale
    OL16 4JF
  • P87027 Langworthy Medical Practice
    Salford
    M6 5WW
  • P87016 The Sides Medical Centre
    Swinton
    M27 0EW
  • P87025 The Lakes Medical Practice
    Swinton
    M27 4AF

Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or 317-615-4559
LillyTrials@Lilly.com


Physicians interested in becoming principal investigators please contact clinical_inquiry_hub@lilly.com



The study is sponsored by Eli Lilly and Company



We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?
Read full details for Trial ID: NCT07247084
Last updated 16 April 2026

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.   

Back to the top